Biotricity, Inc. (NASDAQ:BTCY) Q3 2023 Earnings Conference Call February 14, 2023 4:30 PM ET
Company Participants
Debra Chen - Investor Relations
Waqaas Al-Siddiq - Founder & Chief Executive Officer
John Ayanoglou - Chief Financial Officer
Conference Call Participants
Kevin Dede - H.C. Wainwright
Operator
Greetings, and welcome to the Biotricity's Fiscal Third Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
I will now turn the call over to Debra Chen, Investor Relations.
Debra Chen
Good afternoon, everyone, and welcome to Biotricity's fiscal 2023 third quarter earnings call. As a reminder, Biotricity's third fiscal 2023 quarter ended on December 31, 2022. So, all figures presented for this period will reflect that end date.
Today, Biotricity issued its fiscal 2023 third quarter results press release, which highlighted financial results. A copy of the press release is available on the Investor Relations section of Biotricity's website and full financials will be filed with the SEC on Form 10-Q posted on EDGAR at sec.gov.
Before we begin the company's formal remarks, I'd like to remind listeners that today's discussion may contain forward-looking statements that reflect management's current views with respect to future events. Any such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these forward-looking statements. Biotricity does not undertake to update any forward-looking statements, except as required.
At this point, I'm pleased to turn the call over to Biotricity's Founder and CEO, Dr. Waqaas Al-Siddiq. Please go ahead.
Waqaas Al-Siddiq
Thank you, Debra, and thank you everybody for joining us today. I welcome you to our third quarter fiscal 2023 teleconference.
As I prepared for this call, I reviewed my teleconference notes from our fiscal year 2022 third quarter a year ago, and reminds me how incredibly far we've come in just 12 months. It's easy natural that we momentarily lose sight of this when focusing on the day to day driving marketing initiatives and monitoring ROIs, building sales, interviewing for team expansion, evaluating distributors and negotiating contracts, all while closely watching our cash flow.
Just a year ago, we were still finishing and introducing our new products, building out our cloud-based Biosphere, raising capital and training fresh team members. A year ago, we operated in 26 states. Today, we operate in 32 states. Over the past year, with our product launches and service introductions and upgrades, we have increased our total addressable market 35 times from $1 billion to $35 billion. Just our Bioflux and Biotres solutions alone address a market valued at $6 billion. We believe we are in the right place at the right time.